Please login to the form below

Not currently logged in
Email:
Password:

UCB's Steve Arnold joins ABPI board

Will work to support life sciences in the UK

Steve Arnold joins UCB from GileadThe Association for the British Pharmaceutical Industry (ABPI has appointed UCB's Steve Arnold to its board of management.

Arnold joined UCB in May this year as managing director of the British and Irish Isles folliwng a spell in Canada working for Gilead Sciences.

He will serve as board member of the ABPPI – the UK's trade body for the pharma industry – up to 2014.

“As a leading UK pharma investor, UCB believes that harnessing this scientific innovation and increasing our R&D focus is key to improving the UK's future prosperity and as a member of the ABPI's board of management I will be working to ensure that life sciences remain vibrant in the UK,” said Arnold.

“This is particularly important at such a challenging time for our industry when we are looking for the Government to provide the right fiscal, R&D and commercial environment for our industry to thrive.”

31st July 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics